Coagulopathy associated with factor VIII inhibitor. A literature review
Reece, E.A.; Romero, R.; Hobbins, J.
Journal of Reproductive Medicine 29(1): 53-58
1984
ISSN/ISBN: 0024-7758 PMID: 6423820 Document Number: 227088
Coagulopathy associated with factor VIII inhibitor is a potentially serious medical condition that may mimic the hemostatic failure seen in hemophilia A. This disorder may be detected first during pregnancy or the postpartum period and may cause life-threatening hemorrhagic diathesis. Thirty-three cases of coagulopathy associated with factor VIII inhibitor in the peripartum period have been reported.
Document emailed within 1 workday
Related Documents
Muntean, W. 1984: Purified complex of factor VIII coagulant moiety and phospholipid: high factor VIII coagulant activity in factor VIII inhibitor plasma Wiener Klinische Wochenschrift 96(22): 829-832Brettler, D.B.; Forsberg, A.D.; Levine, P.H.; Aledort, L.M.; Hilgartner, M.W.; Kasper, C.K.; Lusher, J.M.; McMillan, C.; Roberts, H. 1989: The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience Archives of Internal Medicine 149(6): 1381-1385
Mahasandana, C.; Suvatte, V.; Püng-amritt, P.; Tuchinda, S. 1979: Von Willebrand's disease: studies of platelet functions, factor VIII procoagulant activity (F VIII C) and factor VIII-related antigen (F VIII RAg) in three families Southeast Asian Journal of Tropical Medicine and Public Health 10(2): 243-247
Rémy, A.; Avouac, J.; Gossec, L.; Combe, B. 2011: Clinical relevance of switching to a second tumour necrosis factor-alpha inhibitor after discontinuation of a first tumour necrosis factor-alpha inhibitor in rheumatoid arthritis: a systematic literature review and meta-analysis Clinical and Experimental Rheumatology 29(1): 96-103
Brown, J.E.; Carton, C.L.; Hougie, C. 1981: The effect of naturally occurring antibodies to factor VIIi on an immunoradiometric assay for factor VIIi coagulant antigen. Observation on a cross-reacting material-positive (CRM+) hemophiliac with a factor VIIi inhibit Journal of Laboratory and Clinical Medicine 97(1): 65-71
Hauser, I.; Schneider, B.; Lechner, K. 1995: Post-partum factor VIII inhibitors. A review of the literature with special reference to the value of steroid and immunosuppressive treatment Thrombosis and Haemostasis 73(1): 1-5
Takahashi, I.; Furuta, M.; Mizuno, S.; Takamatsu, J.; Kamiya, T. 1993: Effect of substrate and diluent for factor VIIi activity in highly purified factor VIIi concentrate and patient plasma infused factor VIIi concentrate Rinsho Byori. Japanese Journal of Clinical Pathology 41(7): 825-830
Richard, C.; Sedano, C.; Cuadrado, M.A.; Iriondo, A.; Bello, C.; Gandarillas, M.A.; Zubizarreta, A. 1986: Effect of a thymic factor on the concentration of a factor VIIi inhibitor in a patient with treated Hodgkin's disease Thrombosis and Haemostasis 55(2): 299-300
Tran, T.H.; Duckert, F. 1983: Dissociation of factor VIIi procoagulant antigen VIII:CAg and factor VIIi related antigen VIIIR:Ag by EDTA - influence of divalent cation on the binding of VIII:CAg and VIIIR:Ag Thrombosis and Haemostasis 50(2): 547-551
Schoppmann, A.; Waytes, A.T. 1996: Factor VIIi inhibitor and severity of hemophilia Thrombosis and Haemostasis 76(2): 280-281
Aledort, L.M. 1993: World registry on factor VIIi inhibitor patients: why? Seminars in Hematology 30(2 Suppl 1: 7-9
Eckstein, A.; Voss, B.; Taubert, W.; Scheja, J. 1986: A rare case of factor VIII-inhibitor formation Deutsche Zahnarztliche Zeitschrift 41(4): 398-399
Kucharski, W.; Scharf, R.; Ziemski, J.M.; Jaśkowiak, W.; Lopaciuk, S.; Sikora, S.; Siekierski, P. 1997: Factor VIIi inhibitor appearing in women during delivery Ginekologia Polska 68(9): 402-406
Akahori, M.; Yamane, T.; Hino, M.; Ohta, K.; Takubo, T.; Samori, T.; Tatsumi, N. 1999: Non-hemophilic patient with inhibitor against factor VIIi produced after the second delivery Rinsho Byori. Japanese Journal of Clinical Pathology 47(9): 891-895
Ghirardini, A.; Schinaia, N. 1993: Factor VIIi inhibitor. Gruppo Italiano Coagulopatie Congenite Lancet 342(8879): 1110
Carreras, L.O.; Perez, G.N.; Xavier, D.L.; Blanco, A.N.; Penalva, L.B. 1988: Autoimmune factor VIIi inhibitor responsive to gammaglobulin without in vitro neutralisation Thrombosis and Haemostasis 60(2): 343
Tham, C.J.; Trew, M.; Brager, N. 1999: Abnormal clotting and production of factor VIIi inhibitor in a patient treated with venlafaxine Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 44(9): 923-924
Merlini, M.; Moccia, F.; Delucchi, M.; Grillo, G. 2005: Severe bleeding in a case of acquired factor VIIi inhibitor associated with generalized pustular psoriasis Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 20(4): 248-252
Liebe, S. 1982: Activation of the antihemophilic globulin a (factor VIII). 2. Effect of ampholine on the course of blood coagulation and the molecular conformation of factor VIIi Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 37(4): 110-116
Teitel, J.M.; Lau, H.K.; Garvey, M.B. 2002: Discrepancies in measured factor VIIi activity in patients treated with factor VIIi concentrate of human or porcine origin Thrombosis and Haemostasis 88(1): 159-160